Relationship of insulin-like growth factor 1 and bone parameters in 7-15 years old apparently, healthy Indian

Veena H Ekbote1, Vaman V Khadilkar1, Anuradha V Khadilkar1

  • 1Growth and Endocrine Unit, Hirabai Cowasji Jehangir Medical Research Institute, Jehangir Hospital, Pune, Maharashtra, India.

Insights

Insulin-like growth factor 1 (IGF-1) is linked to bone area (BA) and lean body mass (LBM) in children. Higher IGF-1 levels correlate with increased bone and muscle development, impacting skeletal growth.

Area of Science:

  • Pediatric endocrinology
  • Bone biology
  • Body composition analysis

Background:

  • Growth hormone (GH) influences bone growth and mineralization via insulin-like growth factor 1 (IGF-1).
  • Understanding the relationship between IGF-1 and skeletal parameters is crucial for pediatric health.

Purpose of the Study:

  • To evaluate the association between serum IGF-1 concentrations and bone/body composition in children.
  • To assess how IGF-1 relates to bone area (BA), lean body mass (LBM), and bone mineral content (BMC).

Main Methods:

  • Cross-sectional study of 119 children (7.3-15.6 years).
  • Anthropometric parameters measured by standard methods.
  • Bone and body composition assessed using dual-energy X-ray absorptiometry (DXA).
  • Serum IGF-1 concentrations measured via ELISA; Z-scores calculated for IGF-1, BA, LBM, and BMC.

Main Results:

  • No significant gender differences in mean age, serum IGF-1 concentrations, or IGF-1 Z-scores.
  • Children with higher IGF-1 Z-scores exhibited greater LBM and BA Z-scores.
  • Mean BMC for age Z-scores showed no significant difference between high and low IGF-1 groups.

Conclusions:

  • Serum IGF-1 levels show a stronger association with bone area (BA) and lean body mass (LBM).
  • IGF-1's effect on bone is primarily related to periosteal bone acquisition and muscle mass development.
Abstract

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.2K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.8K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
6.0K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
7.5K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.2K
Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
4.8K